Pharmacy Times

Specialty Pharmacy Times

OTC Guide

Pharmacy Times

Risk Evaluation and Mitigation Strategies

Condition Resources

Articles

FDA Announces New REMS for Drugs to Treat Low Platelet Counts

Changes mean pharmacists are no longer are required to enroll in educational programs before dispensing the drugs to patients.

Kate H. Gamble, Senior Editor

Read full article >>

MORE STORIES:

The Changing Landscape of REMS in Pain Management

REMS Improvements Proposed for Version 5 of Prescription Drug User Fee Act

Impact of Risk Evaluation and Mitigation Strategies in Oncology

Assessing a REMS Strategy: Keep It Simple and Responsible

Examining the Role of REMS in Opioid Safety

Clinical Trials

Loading AJAX Content

Latest News

Loading AJAX Content

Multimedia

Concerns about Prescribing Opioids

Getting Ready for REMS

The Necessity for REMS

Practical and Legal Implications of REMS

Updated REMS for Rosiglitazone-containing Medicines

Dasatinib and the Risk of Pulmonary Arterial Hypertension

Impact of REMS on the Health System

Aligning Incentives for Shared Risk and Reward

Events

Las Vegas, NV

September 5-8, 2012

American Journal of Managed Care
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
PainLive
Pharmacy Times
Physician's Money Digest

About Us
Contact Us
Advertise
Terms & Conditions
Newsroom

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.